Brain wave monitor may reduce sedative use in heart surgery ICU patients
NCT ID NCT07350122
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether using a special brain monitor (BIS) to guide sedation can reduce the amount of sedative drugs given to adults in the ICU after heart surgery. About 144 participants will be randomly assigned to either BIS-guided sedation or standard care. The goal is to see if this approach leads to faster recovery and fewer complications like pneumonia or delirium.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Bispectral Index (BIS) monitor
What this could lead to
If it works, this could lead to safer sedation practices for heart surgery patients in the ICU, potentially reducing time on a ventilator and complications like pneumonia or delirium.
What could go wrong
This is a small, early-stage trial with only 144 participants, so results may not apply to all patients. The benefit of BIS monitoring over standard care is unproven, and there is a risk of no significant improvement.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••